For drug registration in Taiwan, safety requirements include comprehensive preclinical and clinical trials to assess toxicity and efficacy, ensuring the drug poses minimal risk to patients. The TFDA also mandates pharmacovigilance plans and post-market surveillance to monitor adverse effects. Compliance with Good Manufacturing Practice (GMP) further guarantees consistent product safety throughout production.
